title: Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation.
authors.forename: Oliver
authors.initials: O
authors.lastname: Grottke
authors.forename: Markus
authors.initials: M
authors.lastname: Honickel
authors.forename: Joanne
authors.initials: J
authors.lastname: van Ryn
authors.forename: Hugo
authors.initials: H
authors.lastname: ten Cate
authors.forename: Rolf
authors.initials: R
authors.lastname: Rossaint
authors.forename: Henri M
authors.initials: HM
authors.lastname: Spronk
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D000069604:Dabigatran / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D013552:Swine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; C000594745:idarucizumab; D000069604:Dabigatran